1. Wong MC, Goggins WB, Wang HH, et al. Global incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries. Eur Urol. 2016;70:862–74.
2. Andrology Australia. Androgen Deprivation Therapy (ADT). 2018. [Available from:
https://www.andrologyaustralia.org/androgen-deprivation-therapy/
3. Kumar R, Barqawi A, Crawford D. Adverse events associated with hormonal therapy for prostate cancer. Rev Urol. 2005;7(Suppl5):S37–43.
4. Galvão DA, Spry NA, Taaffe DR, et al. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. BJU Int. 2008;102:44–7.
5. Moyad M, Newton R, Tunn U, Gruca D. Integrating diet and exercise into care of prostate cancer patients on androgen deprivation therapy. Res Rep Urol. 2016;8:133–43.